Determination of Ebrotidine (cas 100981-43-9) and its metabolites by capillary electrophoresis with UV and mass spectrometry detection
-
Add time:08/24/2019 Source:sciencedirect.com
This study describes the application of capillary electrophoresis (CE) to the analysis of Ebrotidine (cas 100981-43-9) and its metabolites as an alternative analytical technique to liquid chromatography. Comparison between UV–diode array spectroscopy and mass spectrometry (MS) using an ion-trap system with electrospray ionization as detection systems has been performed. The quality parameters of the UV detection method were established, obtaining linear calibration curves over the range studied (8–200 mg ml−1), limits of detection between 3.4 and 4.3 μg ml−1, and run-to-run and day-to-day precision lower than 14%. For these compounds the protonated species [M+H]+ and, in some cases, sodium adducts were observed in the MS spectra. Using MS coupled to CE, limits of detection were between 0.5 and 2.6 μg ml−1.
We also recommend Trading Suppliers and Manufacturers of Ebrotidine (cas 100981-43-9). Pls Click Website Link as below: cas 100981-43-9 suppliers
Prev:General paperEffect of Ebrotidine (cas 100981-43-9) on the synthesis and secretion of gastric sulfomucin
Next:Revisiting the parcel method and CAPE (cas 100981-80-4)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- General paperEffect of Ebrotidine (cas 100981-43-9) on the synthesis and secretion of gastric sulfomucin08/23/2019
- General paperInhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: Effect of Ebrotidine (cas 100981-43-9)08/22/2019
- General paperEnhancement in the protective qualities of gastric mucus by Ebrotidine (cas 100981-43-9) during duodenal ulcer healing08/21/2019
- Determination of Ebrotidine (cas 100981-43-9) and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography08/20/2019
- Ebrotidine (cas 100981-43-9) effect on the proteolytic and lipolytic activities of Helicobacter pylori08/19/2019
- General paperGastric mucosal laminin receptor expression with ulcer healing by Ebrotidine (cas 100981-43-9)08/18/2019
- General paperEnhancement of gastric mucus phospholipid secretion by an antiulcer agent, Ebrotidine (cas 100981-43-9)08/17/2019
- Acute liver injury associated with the use of Ebrotidine (cas 100981-43-9), a new H2-receptor antagonist08/16/2019
- Determination of Ebrotidine (cas 100981-43-9) and its metabolites by micellar electrokinetic capillary chromatography08/15/2019


